全新成纤维细胞生长因子李校堃9787040528695

The FGF Metabolic Axis

Chapter 1 Growth Factors Reviews

Fibroblast growth factors，old kids on the new block

Pharmacological application of growth factors： basic and clinical

Cytokines and diabetes research

Small molecule inhibition of fibroblast growth factor receptors in cancer

Research advances in tissue engineering materials for sustained release of growth factors

Minireview： roles of fibroblast growth factors 19 and 21 in metabolic regulation and chronic diseases

Physiological and pharmacological roles of FGF21 in cardiovascular diseases

Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury

Delivery of growth factor-based therapeutics in vascular diseases： challenges and strategies

Fibroblast growth factr 0 in pancreas develomn ad pancreatic cancer

Chapter 2 Injury Repair and Regeneration

TAT-mediated acidic fibroblast growth factor delivery to the dermis irve wound healing of deep skin tissue in rat

Regulation of autophagy and ubiquitinated protein accumulation by bFGF promotes functional recovery and neural protectzion in a

rat model of spinal cord injury

The anti-scar effects of basic fibroblast growth factor on the wound repair in vitro and in vivo

Exogenous basic fibroblast growth factor inhibits ER Stress-induced apoptosis and irve recovery from spinal cord injury

FGF10 protects against renalischemia/reperfusion injury by regulating autophagy and infiammatory signaling

Reduction of llar stress is essential for Fibroblast growth factr treatment for diabetic nephropathy

Chapter 3 Endocrinology and Metabolism

Fibroblast growth factor 21 （FGF21） therapy attenuates left ventricular dysfunction and metabolic disturbance by improving

FGF21 sensitivity，cardiac mitochondrial redox homoeostasis and structural changes in pre-diabeticrats

NMR-based metabolomics reveal a recovery from metabolic changes in the striatum of 6-OHDA-induced rats treated with basic

fibroblast growth factor

FGF21 mediates alcohol-induced adipose tissuelipolysis by activation of systemic release of catecholamine inmice

Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice

Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model

FGF21 deletion exacerbates diabetic cardiomyopathy by aggravatin ariac lipid accumulation

Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and

induction of adiponetiinice

Attenuation of hyperlipidemia and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration

offibroblast growth factor-21 is associated with suppression of renal infiammation

The prevention of diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth factor is probably mediated by the

suppression of otive stress and damage

Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a

PI3K/Akt signaling-dependent manner

……

Chapter 4 Structure and Modification

Chapter 5 Signaling Pathway and Pharmacology

Chapter 6 Pharmaceutics and New Material

Chapter 7 Bioreactor and Engineering

Chapter 8 FGFR and Inhibitors

Chapter 9 Others